New research suggests risk of suicide attempt is increased by the interaction of bipolar disorder genetic risk and trauma
A recent study has suggested that physicians could determine whether a patient has major depression or bipolar disorder with a simple short electrocardiogram.
Genetic variant relating to protein involved in neurotransmission may affect brain’s ability to regulate emotion.
Stem cell-derived neurons in the development of targeted treatment for schizophrenia and bipolar disorder
Insight into the current research areas utilizing stem cell models to provide new evidence of the pathobiology of schizopheria and bipolar disorder, followed by how this can influence the development of new targeted therapies.
The authors assess the value of utilizing pharmacogenetic information to improve antidepressant drug therapy in BPD patients.
In this #NCMentalHealthMonth interview, we speak to Miriam Greenberg and Wenxi Yu, who discuss the current hypotheses surrounding the therapeutic mechanisms of anti-bipolar drugs, as well as their hopes for the future of the field of bipolar disorder therapeutics.
Genetic variation and the D2 dopamine receptor: implications for the treatment of neuropsychiatric disease
In this article, the author discusses genetic variation of the D2 dopamine receptor and the implications this has for the treatment of neuropsychiatric disease.
Researchers discover an association between bipolar disorder and genes of the striatum.
This article discusses some of the biochemical effects of neuropsychiatric drugs for bipolar disorder, focusing in on inositol depletion and GSK3 inhibition interrelatedness as an explanation for valproic acid and lithium efficacy.
For the first time, utilizing a newly developed experimental model for bipolar disease, researchers have successfully analyzed the neurotoxicity of bipolar patient blood.